CIK 0001130166
- Non-accelerated filer
- Smaller reporting company
Bio Green Med Solution, Inc.
Sign in to watch- Tickers
- BGMS BGMSP
- Exchange
- Nasdaq, OTC
- Industry
- Wholesale-Durable Goods, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 911766850
- Phone
- +1 908-517-7330
- Business address
- 200 CONNELL DRIVE, SUITE 1500, BERKELEY HEIGHTS, NJ, 07922
- Former names
- Cyclacel Pharmaceuticals, Inc., XCYTE THERAPIES INC
Securities
- BGMS Common Stock Nasdaq
- BGMSP Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-07-30 | Lazar David E. 10% owner | Sale | −6,750 | $12.36 | $83K | 155,838 |
| 2025-02-26 | Lazar David E. Interim CEO | Exercise or conversion | +2,650,000 | 2,650,000 | ||
| 2025-02-26 | Lazar David E. Interim CEO | Exercise or conversion | +191,978,820 | 194,628,820 | ||
| 2025-02-26 | Lazar David E. Interim CEO | Sale | −194,628,820 | $0.03 | $5.5M | 0 |
| 2025-02-26 | Lazar David E. Interim CEO | Exercise or conversion · Series C Convertible Preferred Stock | −1,000,000 | 0 | ||
| 2025-02-26 | Lazar David E. Interim CEO | Exercise or conversion · Series D Convertible Preferred Stock | −1,745,262 | 354,738 | ||
| 2025-02-06 | Lazar David E. Interim CEO | Grant or award · Series D Convertible Preferred Stock | +2,100,000 | 2,100,000 |
Page 1 of 1 · 7 trades